Skip to main content
. 2019 Oct 25;14(10):e0223857. doi: 10.1371/journal.pone.0223857

Table 1. Characteristics of IE patient, France 2011.

Characteristics n = 6,235 (%)
Male gender 4,003 (64.2)
Age, mean, (median, 25%, 75%) 69 (72, 60, 81)
Predisposing diseases
Chronic cardiac disease 1,701 (27.3)
Diabetes mellitus 1,479 (23.7)
Cancer 1,004 (16.1)
Chronic renal disease 1,251 (20.1)
Chronic respiratory disease 894 (14,3)
Intravenous drug use 125 (2.0)
 Hemodialysis dependence 345 (5.5)
Valve status
Native valve 4,488 (72.0)
Valve prosthesis 1,247 (20.0)
Unknown 500 (8.0)
Pacemaker 1,025(16.4)
Microorganism
 Monomicrobial 3,490 (56.0)
Streptococci/Enterococci 1,557(44.6)
Staphylococci 1,531 (43.9)
Gram-negative bacilli 317 (9.1)
Candida sp. 46 (1.3)
Coxiella burnetii 17 (0.5)
Bartonella henselae 3 (0,1)
Polymicrobial 513 (8.2)
 Not documented 2,232 (35.8)
  No microbiological code 1,994(89.3)
  Code for non-specified pathogen 238 (10.7)
Complication
 Cardiogenic shock 511 (8.2)
 Stroke 803 (12.9)
  Ischemic stroke 586 (73.0)
  Hemorrhagic stroke 217 (27.0)
 Acute ischemia of lower limb 158 (2.5)
 Vertebral osteomyelitis 292 (4.7)
Valvular surgery 1,576 (25.3)
 During initial stay 635 (40.3)
 During one year follow-up 941 (59.7)
Death 1,814 (29.1)
 During initial IE hospital stay 1,283 (70.7)
 Death during follow-up 531 (29.3)